{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:51:04Z","timestamp":1786636264020,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0028-3886.68656","type":"journal-article","created":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T04:21:32Z","timestamp":1282623692000},"page":"507","source":"Crossref","is-referenced-by-count":6,"title":["Solitary cysticercus granuloma-treatment with albendazole: What is the optimal duration?"],"prefix":"10.4103","volume":"58","author":[{"given":"Gagandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.K","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.68656-1","first-page":"359","volume-title":"Long-term results of praziquantel therapy in neurocysticercosis","author":"Robles","year":"1987","journal-title":"J Neurosurg"},{"key":"key-10.4103\/0028-3886.68656-2","first-page":"738","volume-title":"Albendazole therapy for neurocysticercosis","author":"Escobedo","year":"1987","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0028-3886.68656-3","first-page":"1130","volume-title":"Short course of albendazole therapy for neurocysticercosis","author":"Sotelo","year":"1988","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0028-3886.68656-4","first-page":"532","volume-title":"Albendazole vs praziquantel for therapy for neurocysticercosis.A controlled trial","author":"Sotelo","year":"1988","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0028-3886.68656-5","first-page":"249","volume-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","author":"Garcia","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.68656-6","first-page":"1050","volume-title":"Effects of albendazole treatment on neurocysticercosis: A randomised controlled trial","author":"Carpio","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.68656-7","first-page":"696","volume-title":"Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: A randomized, placebo-controlled, double blind trial","author":"Baranwal","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0028-3886.68656-8","first-page":"416","volume-title":"Neurocysticercosis in children: Clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases","author":"Gogia","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0028-3886.68656-9","first-page":"111","volume-title":"Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial","author":"Kalra","year":"2003","journal-title":"J Pediatr"},{"key":"key-10.4103\/0028-3886.68656-10","first-page":"1344","volume-title":"Albendazole in single CT ring lesions in epilepsy","author":"Padma","year":"1994","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.68656-11","first-page":"43","volume-title":"Meta-analysis: Cysticidal drugs for neurocysticercosis: Albendazole and praziquantel","author":"Del","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0028-3886.68656-12","first-page":"560","volume-title":"Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion","author":"Kaur","year":"2010","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.68656-13","first-page":"1421","volume-title":"Albendazole therapy for neurocysticercosis: A prospective double-blind trial comparing 7 versus 14 days of treatment.Cysticercosis Working Group in Peru","author":"Garcia","year":"1997","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.68656-14","first-page":"1079","volume-title":"Single-day praziquantel versus 1-week albendazole for neurocysticercosis","author":"Del","year":"1999","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.68656-15","first-page":"125","volume-title":"Single-day praziquantel therapy for neurocysticercosis","author":"Corona","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.68656-16","first-page":"215","volume-title":"Short regimen of praziquantel in the treatment of single brain enhancing lesions","author":"Pretell","year":"2000","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:55:27Z","timestamp":1786632927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.68656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"alternative-id":["68656"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.68656","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}